Connect with us

COVID-19

Kogi surrenders, agrees to roll out COVID-19 vaccine this week

Published

on

After repeatedly doubting the existence of the COVID-19 in Kogi, the state government has finally accepted to start administering the vaccine to its residents.

The State Commissioner for Health, Saka Haruna, said Kogi would receive doses of the vaccine on Tuesday ahead of the roll-out.

He also said the residents would be given “unhindered access to receive the vaccine”.

Kogi’s decision to start administering the Oxford/AstraZeneca vaccine to residents is coming three weeks after Nigeria began its roll-out.

The National Primary Health Care Development Agency (NPHCDA) had attributed the delay to two factors: The state’s “concerns around the contradictory information about the vaccines” and the non-repair of its cold-chain store.

When the vaccine doses arrived in Nigeria, the Kogi State Governor, Yahaya Bello, who had repeatedly denied the existence of COVID-19 in the state, said the vaccination was one of their least concerns.

“COVID-19 is just a minute aspect of what we’re treating in Kogi State. I’m not going to subject the people of Kogi State to vaccination, or I will not make them guinea pigs,” he had said.

But on Monday, Haruna said everything looked set for the state to start the vaccination roll-out.

“We have done the micro-planning and everything has been completed with the National Primary Health Care Development Agency (NPHCDA),” the commissioner said in a phone interview with TheCable.

He added, “Anybody that is willing to receive the vaccine (will receive it); nobody is exempted. And nobody will be forced to receive the vaccine.”

He said the state would announce further plans including the location of the vaccination launch after receiving the supplies.

He, however, failed to confirm if state government officials particularly the governor would receive the vaccine.

“The governor does not have to receive the vaccine before others will; I don’t think there is anything special about COVID that we have to bring the governor out to come and receive the vaccine,” he said.

COVID-19

US to halt J&J COVID vaccine after blood clotting cases

Published

on

The United States federal health agencies on Tuesday recommended suspending the use of the Johnson & Johnson COVID-19 vaccine.

The development comes after six recipients of the vaccine — all women– developed a “severe type of blood clot”.

The Food and Drug Administration (FDA) and the Center for Disease Control and Prevention (CDC) said they would stop using the vaccine at federal sites and asked states to do so as well while they investigate safety issues.

The agencies, in a joint statement, said they were “reviewing data involving six reported US cases of a rare and severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare”.

“Treatment of this specific type of blood clot is different from the treatment that might typically be administered,” they said.

“CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.

“Until that process is complete, we are recommending this pause. This is important to ensure that the health care provider community is aware of the potential for these adverse events and can plan due to the unique treatment required with this type of blood clot.”

It is the third COVID-19 vaccine that has received FDA’s authorisation, and also the first single-dose COVID-19 vaccine available in the US.

About seven million people in the US have received the vaccine.

Similar reports of blood clot development in recipients of the AstraZeneca vaccine made several European countries to suspend use of the product in March.

They have, however, resumed using the vaccine after European Union and British regulators said there was no link between the vaccine and the reported side effects.

Continue Reading

COVID-19

COVID-19: PTF transforms into presidential steering committee, completes task December

Published

on

COVID-19: PTF transforms into presidential steering committee, complete task December

President Muhammadu Buhari has approved the transition of the Presidential Task Force (PTF) on COVID-19 to the presidential steering committee.
Secretary to the Government of the Federation, Boss Mustapha, said President Muhamadu Buhari, stated this at a media briefing on Tuesday, adding that the mandate of the PSC would end on December 31.
According to him, the PSC will focus on ensuring effectiveness in the roll-out of the vaccine, and promote policies that will result in the development of the country’s health sector.
“Mr president has considered the report and has approved the following: That the PTF will transition to a presidential steering committee on COVID-19, effective from 1st April, 2021, with a modified mandate to reflect the non-emergent status of COVID-19 as a potentially long-term pandemic,” he said.
“That the structure of the PSC shall reflect the new focus of the response with a targeted approach on vaccine oversight, risk communication, international travel quarantine processes and sub-national engagement; that the tenure of the presidential steering committee shall last till 31st December, 2021.
“The presidential steering committee would maintain the present constitution, functions and strategies of the PTF; be supported by a slim technical and administrative structure.”

Continue Reading

COVID-19

Lagos shuts 430 event centres, night clubs

Published

on

The Lagos State Safety Commission says it has shut 430 event centres and night clubs for violating COVID-19 protocols.
Director General at the commission, Lanre Mojola, said at a news conference in Alausa, Ikeja that the commission was saddled with developing safety guidelines for the state’s reopening of economic activities in post COVID-19 lockdown.
“The commission was involved in the enforcement of COVID-19 protocols and this led to the shutting of 30 event centres and 400 clubs across the state,” he added.
On construction safety, the DG said the commission carried out risk assessment and unscheduled safety inspection of construction sites to ensure safety compliance, as well as adherence to COVID-19 protocols, to prevent accidents, incidents, illnesses and loss of lives.
He said the commission issued provisional safety compliance certificates for 90 days and safety compliance certificates thereafter if compliance status was maintained.
Mojola said the enforcement was carried out in 609 construction sites for repeated failure to comply with safety regulations.
He said the annual World Safety Day would hold across the world on April 28 to create awareness, sensitise and educate people on the importance of keeping the workplace safe and free from occupational hazards, accidents, incidents and preventable illnesses.

Continue Reading

Trending